Sandoz (SDZ) confirms approval of Ondibta by the EU Commission; strengthening their overall Biosimilars leadership and position in diabetes
Sandoz's confirmation of EU approval for Ondibta is a pivotal development, reinforcing its leadership in the biosimilars market, especially in diabetes care.
HSBC (HSBA LN) is reportedly considering the sale of its Singaporean insurance business, according to sources
SLB (SLB) is poised to reap gains from Trump’s plan to leverage Venezuelan oil, is in position to win some of the first contracts under plan to revive Venezuela’s ailing oil industry, FT reports
Sandoz (SDZ) confirms approval of Ondibta by the EU Commission; strengthening their overall Biosimilars leadership and position in diabetes
China's State Administration for Market Regulation has commenced an investigation on Trip.com (TCOM) under anti-monopoly laws of PRC; Trip says it is cooperating, business operations remain normal
Russian Foreign Minister Lavrov says, regarding reports that US ambassadors could visit Moscow, says President Putin is willing to have serious talks. Discussion of a Ukraine ceasefire is not serious.
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This move could enhance Sandoz's competitive edge, potentially driving stock performance and investor interest in the broader pharmaceutical sector, particularly among peers focusing on diabetes treatments.
Related headlines
- Stellantis (STLAM IM/STLAP FP) plans to invest EUR 1bln+ to design and build a new van in France2 days ago
- Ipsen (IPN FP) CEO says that they are considering potential US manufacturing investment for plant to make neuroscience drugs2 days ago
- European Movers: Alstom (ALO FP) +1.7%, Airbus (AIR FP) +1.6%, UniCredit (UCG IM) +1%, Commerzbank (CBK GY) +0.6%, SAP (SAP GY) -1.6%2 days ago
- Additional European Equity News - 11th September 20262 days ago
- European Equity pre-Market Summary - 11th September 2026: European bourses rebound, with focus on the US CPI2 days ago
- Newsquawk Daily European Equity Opening News - 11th September 20262 days ago
- Ryanair (RYA ID) CEO says that if oil prices remain higher into the next year, then he believes that there will be a "significant" uplift in airfares; have stopped hedging oil prices in recent weeks3 days ago
- European Movers: Fortum (FORTUM FH) +3%, Porsche AG (P911 GY) +1.4%, Novartis (NOVN SW) +0.8%, Associated British Foods (ABF LN) -10%3 days ago
- Additional European Equity News - 10th September 20263 days ago
- European Equity pre-Market Summary - 10th September 2026: European bourses set for a mildly firmer open; Porsche AG lifts guidance3 days ago
- Newsquawk Daily European Equity Opening News - 10th September 20263 days ago
- Crystler (STLAM IM/STLAP FP) files to recall over 200k US vehicles4 days ago
- European Movers: Airbus (AIR FP) -1.3%, LVMH (MC FP) -1.3%, Orsted (ORSTED DC) -1.6%, Inditex (ITX SM) -3%, Burberry (BRBY LN) -3%4 days ago
- Additional European Equity News - 9th September 20264 days ago
- European Equity pre-Market Summary - 9th September 2026: European bourses are indicative of a slightly softer open; Inditex reports poor results4 days ago
- Newsquawk Daily European Equity Opening News - 9th September 20264 days ago
- European Movers: Airbus (AIR FP) -0.7%, Schneider Electric (SU FP) -0.9%, Société Générale (GLE FP) -1.6%, Infineon (IFX GY) -1.9%, Novartis (NOVN SW) -9%, 5 days ago
- Additional European Equity News - 8th September 20265 days ago
- European Equity pre-Market Summary - 8th September 2026: Novartis does not meet Phase 3 primary endpoint; European equity futures indicative of a slightly lower open, as energy picks up5 days ago
- Newsquawk Daily European Equity Opening News - 8th September 20265 days ago
The whole workspace, free to try.
Try it free